ZDG-33841-11141
2 vaccinations
2 coded responses
7 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 761 / TX
- Registered
- 2021-03-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-05
Dose 1 — Moderna
-
2021-03-18
Registered in v-safe
- 2021-03-18
- 2021-03-28
-
2021-04-05
Dose 2 — Moderna
-
2021-04-11
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Headache, Joint pains, Fatigue or tiredness, Abdominal painAdult check-in
- 2021-05-17
- 2021-07-05
-
2021-10-04
Survey response — 6 months, dose 2MedDRA: Anxiety, Brain fog, Fatigue, Headache, Heavy menstrual bleeding, Tremor — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Headaches Heavy menstrual cycles Increased anxiety Shakiness Brain fog Daily fatigueMedDRA releases: 2024-11 · check-in free text available
-
2022-04-07
Survey response — 12 months, dose 2MedDRA: Anxiety, Depression, Fatigue — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Anxiety depression and fatigueMedDRA releases: 2024-11 · check-in free text available
-
2022-04-07
Report sent to call center — 12 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-04-11
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-05 | Moderna | |
| 2 | 2021-04-05 | Moderna |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-04-07 | Successful 2022-04-11 |
Participant prefers to complete VAERS report online |
Free text
Release 10 — 6 months, dose 2
Symptoms: Headaches Heavy menstrual cycles Increased anxiety Shakiness Brain fog Daily fatigue
Release 11 — 12 months, dose 2
Symptoms: Anxiety depression and fatigue
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Anxiety | · | · | ✓ |
| SD | Brain fog | · | · | ✓ |
| SD | Depression | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Heavy menstrual bleeding | · | · | ✓ |
| SD | Tremor | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release